Can Upper Ureteral Kidney Stones Be Treated with Extracorporeal Shock Wave Lithotripsy?

Patients diagnosed with upper ureteral stones—those located in the proximal segment of the ureter, typically within 2 cm of the ureteropelvic junction—may be candidates for extracorporeal shock wave lithotripsy (ESWL). This noninvasive procedure uses focused acoustic shock waves to fragment calculi into smaller particles that can then pass spontaneously through the urinary tract.

However, ESWL success rates for upper ureteral stones are highly dependent on several factors: stone size (optimal if <10 mm), composition (calcium-based stones respond better than uric acid or cystine stones), patient anatomy (e.g., body habitus, ureteral tortuosity, and presence of stenosis), and stone density as assessed by non-contrast CT. Stones larger than 15 mm or those associated with significant hydronephrosis or infection generally warrant alternative interventions such as ureteroscopy (URS) or, less commonly, percutaneous nephrolithotomy (PCNL).

Clinical guidelines—including those from the American Urological Association (AUA) and European Association of Urology (EAU)—recommend ESWL as a first-line option for uncomplicated upper ureteral stones ≤10 mm in appropriately selected patients. Success is measured by stone-free status at four weeks post-treatment, with reported efficacy ranging from 70% to 90% in favorable cases. Adjunctive medical expulsive therapy (MET), typically with alpha-blockers like tamsulosin, may improve stone passage rates following ESWL.

Contraindications include uncontrolled hypertension, bleeding diathesis, pregnancy, and distal ureteral obstruction preventing fragment clearance. Close follow-up with imaging—usually low-dose non-contrast CT or ultrasound—is essential to assess treatment response and detect complications such as steinstrasse (a “stone street” causing ureteral obstruction) or persistent obstruction requiring secondary intervention.